Terminal uridylyltransferases target RNA viruses as part of the innate immune system.

["Le Pen, J\u00e9r\u00e9mie", "Jiang, Hongbing", "Di Domenico, Tom\u00e1s", "Kneuss, Emma", "Kosa\u0142ka, Joanna", "Leung, Christian", "Morgan, Marcos", "Much, Christian", "Rudolph, Konrad L M", "Enright, Anton J", "O'Carroll, D\u00f3nal", "Wang, David", "Miska, Eric A"]
Nature structural & molecular biology 2018
Open on PubMed

RNA viruses are a major threat to animals and plants. RNA interference (RNAi) and the interferon response provide innate antiviral defense against RNA viruses. Here, we performed a large-scale screen using Caenorhabditis elegans and its natural pathogen the Orsay virus (OrV), and we identified cde-1 as important for antiviral defense. CDE-1 is a homolog of the mammalian TUT4 and TUT7 terminal uridylyltransferases (collectively called TUT4(7)); its catalytic activity is required for its antiviral function. CDE-1 uridylates the 3' end of the OrV RNA genome and promotes its degradation in a manner independent of the RNAi pathway. Likewise, TUT4(7) enzymes uridylate influenza A virus (IAV) mRNAs in mammalian cells. Deletion of TUT4(7) leads to increased IAV mRNA and protein levels. Collectively, these data implicate 3'-terminal uridylation of viral RNAs as a conserved antiviral defense mechanism.